Apogee Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Apogee Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Apogee Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apogee Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $32M | 800k | 39.74 |
| 2025-06-30 | $4.7M | 107k | 43.43 |
| 2025-03-31 | $26M | 702k | 37.36 |
| 2024-12-31 | $25M | 541k | 45.30 |
| 2024-09-30 | $3.0M | 52k | 58.74 |
| 2024-06-30 | $2.0M | 51k | 39.35 |
| 2024-03-31 | $5.1M | 76k | 66.45 |
| 2023-09-30 | $76k | 3.6k | 21.30 |